Literature DB >> 8011975

Renal cell carcinoma in autosomal dominant polycystic kidney disease.

D S Keith1, V E Torres, B F King, H Zincki, G M Farrow.   

Abstract

To provide information on the clinical presentation, diagnosis, pathology, and biologic behavior of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease (ADPKD), three cases seen at this institution between 1955 and 1992, as well as the cases reported in the literature, were reviewed in detail. No male predominance was observed (12 men, 13 women) in the 25 patients who met the inclusion criteria. The age of presentation was earlier than that seen in the general population (45 versus 61 yr). Fever, night sweats, and weight loss were prominent at presentation. Fever is a more common presenting symptom of renal cell carcinoma in ADPKD (32%) than in the general population (7%). Twenty percent of the patients had metastatic disease at presentation. Even with computed tomography and magnetic resonance, the diagnosis was difficult and often delayed, and the accumulation of 111In-labeled white blood cells can wrongly suggest a cyst infection. Renal cell carcinoma in ADPKD is more often concurrently bilateral (12 versus 1 to 5%), multicentric (28 versus 6%), and sarcomatoid in type (33 versus 1 to 5%) than in the general population. Because previous studies have failed to demonstrate a higher prevalence of renal cell carcinoma in ADPKD, this information suggests either a malignant potential restricted to a small subset of patients with this disease or an alteration in the biologic behavior of renal cell carcinoma when it develops in the setting of ADPKD.

Entities:  

Mesh:

Year:  1994        PMID: 8011975     DOI: 10.1681/ASN.V491661

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  29 in total

1.  Lesson of the week: Causes of haematuria in adult polycystic kidney disease.

Authors:  R Dedi; S Bhandari; J H Turney; A M Brownjohn; I Eardley
Journal:  BMJ       Date:  2001-08-18

Review 2.  The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.

Authors:  Tamina Seeger-Nukpezah; Daniel M Geynisman; Anna S Nikonova; Thomas Benzing; Erica A Golemis
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

3.  Native nephrectomy in transplant patients with autosomal dominant polycystic kidney disease.

Authors:  P Patel; C Horsfield; F Compton; J Taylor; G Koffman; J Olsburgh
Journal:  Ann R Coll Surg Engl       Date:  2011-07       Impact factor: 1.891

4.  Sarcomatoid renal cell carcinoma with autosomal dominant polycystic kidney disease: a case report and literature review.

Authors:  Yuji Hakozaki; Kiyotaka Uchiyama; Akane Yanai; Daisuke Yamada; Yuka Kamijo; Yoshitaka Ishibashi
Journal:  CEN Case Rep       Date:  2020-10-16

Review 5.  Evaluation and management of pain in autosomal dominant polycystic kidney disease.

Authors:  Marie C Hogan; Suzanne M Norby
Journal:  Adv Chronic Kidney Dis       Date:  2010-05       Impact factor: 3.620

6.  [Pitfalls and outcome of nephrectomy for patients with polycystic kidney disease: Peri- and postoperative results].

Authors:  D Pfister; D Thüer; A Heidenreich
Journal:  Urologe A       Date:  2010-09       Impact factor: 0.639

Review 7.  ADPKD-what the radiologist should know.

Authors:  Pritika Gaur; Wladyslaw Gedroyc; Peter Hill
Journal:  Br J Radiol       Date:  2019-04-30       Impact factor: 3.039

8.  The incidence of urinary tract cancers is related to preserved diuresis: a single-center report.

Authors:  Vedran Premuzic; Marija Gamulin; Marijana Coric; Bojan Jelakovic
Journal:  Int Urol Nephrol       Date:  2017-10-16       Impact factor: 2.370

9.  Xp11.2 translocation renal cell carcinoma in the autosomal dominant polycystic kidney disease patient with preserved renal function.

Authors:  Hyuk Huh; Hyung Ah Jo; YongJin Yi; Seung Hyup Kim; Kyung Chul Moon; Curie Ahn; Hayne Cho Park
Journal:  Korean J Intern Med       Date:  2017-10-17       Impact factor: 2.884

10.  Novel insights into the role of the tumor suppressor von Hippel Lindau in cellular differentiation, ciliary biology, and cyst repression.

Authors:  Michael S Wiesener; Patrick H Maxwell; Kai-Uwe Eckardt
Journal:  J Mol Med (Berl)       Date:  2009-07-24       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.